Physician profile
Luke D Krautter
NPI 1336434992
$14,687.18
in general payments reported to CMS, 2019-2025
78 companies · $2,176 in 2025
The $2,176 reported for 2025 was more than what 96% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,079 · 2020: $1,574 · 2021: $2,313 · 2022: $2,876 · 2023: $2,560 · 2024: $2,109 · 2025: $2,176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,845.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,844.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,624.63 | 2021-2025 | |
| Novo Nordisk INC | $1,526.78 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $1,058.03 | 2019-2025 | Repatha, Otezla, Otezla |
| Glaxosmithkline, LLC. | $1,057.80 | 2020-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Lilly USA, LLC | $742.55 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $680.42 | 2019-2025 | Farxiga, Airsupra, Evusheld |
| Boehringer Ingelheim Pharmaceuticals, INC. | $538.24 | 2019-2023 | Jardiance |
| Pfizer INC. | $510.19 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $398.23 | 2020-2025 | Verquvo, Belsomra, Steglatro |
| Novartis Pharmaceuticals Corporation | $359.45 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $349.33 | 2021-2025 | |
| Corium, LLC | $300.69 | 2022-2025 | Azstarys |
| Sanofi-Aventis U.S. LLC | $293.83 | 2019-2023 | |
| Otsuka America Pharmaceutical, INC. | $281.56 | 2020-2025 | Rexulti |
| Teva Pharmaceuticals USA, INC. | $253.07 | 2019-2025 | Austedo Xr |
Show all 78 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luke Krautter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.